Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Basu: Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic.... (0.07 sec) 

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin


K Overbeck, D Genné, A Golay, F Negro - Journal of Hepatology, 2008 - Elsevier
Insulin resistance reduces the response to interferon alfa-based therapy of
chronic hepatitis C patients. It has been speculated that improvement of insulin
sensitivity might increase the chances of responding to treatment of such ...
Cited by 16 - Related articles - All 2 versions

Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose …

- physiology.org
SK Das, WS Chu, AK Mondal, NK Sharma, PA … - American Journal of Physiology- Endocrinology And …, 2008 - Am Physiological Soc
Obesity and elevated cytokine secretion result in a chronic inflammatory state
and may cause the insulin resistance observed in type 2 diabetes. Recent studies
suggest a key role for endoplasmic reticulum stress in hepatocytes and ...
Cited by 4 - Related articles - All 5 versions

The influence of sex, body composition, and nonesterified fatty acids on serum adipokine …


EP Plaisance, PW Grandjean, RL Judd, KW … - Metabolism, 2009 - Elsevier
Serum adiponectin concentrations are higher in women than men. The sexual
dimorphism for adiponectin has been attributed to the direct effects of
testosterone on adipose tissue adiponectin secretion. However, serum ...
Cited by 1 - Related articles - All 5 versions

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but …


AS Felts, BS Siegel, SM Young, CW Moth, TP … - Journal of medicinal chemistry, 2008 - pubmedcentral.nih.gov
A series of novel derivatives of the nonsteroidal anti-inflammatory drug (NSAID)
sulindac sulfide were synthesized as potential agonists of the peroxisome
proliferator-activated receptor gamma (PPARγ). Nonpolar and aromatic ...
Cited by 1 - Related articles - All 7 versions

Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes

- nih.gov
R Basu, A Basu, V Chandramouli, B Norby, B … - Diabetologia, 2008 - Springer
Page 1. ARTICLE Effects of pioglitazone and metformin on NEFA-induced insulin
resistance in type 2 diabetes R. Basu & A. Basu & V. Chandramouli & B. Norby & ...
Cited by 1 - Related articles - All 4 versions

Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in …


A Gastaldelli, A Casolaro, D Ciociaro, S … - American Journal of Physiology- Endocrinology And …, 2009 - Am Physiological Soc
Pioglitazone has been shown to reduce fasting triglyceride levels. The
mechanisms of this effect have not been fully elucidated, but decreased
lipolysis may contribute to blunt the hypertriglyceridemic response to a ...
Cited by 1 - Related articles - All 3 versions

Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea …


M Roden, S Mariz, AR Brazzale, G Pacini - Journal of Internal Medicine, 2009 - pt.wkhealth.com
Roden M, Mariz S, Brazzale AR, Pacini G (Heinrich Heine University, Düsseldorf,
Germany; Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna,
Austria; Takeda Global Research & Development Centre (Europe) Ltd, London, ...
Related articles - All 5 versions

Plasma C5 Glucose–to–2H2O Ratio Does Not Provide an Accurate Assessment of …

- nih.gov
R Basu, V Chandramouli, B Dicke, BR Landau … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—Plasma C2 glucose and plasma 2 H 2 O enrichment were equal in both
groups before the clamp, resulting in equivalent estimates of gluconeogenesis
and glycogenolysis. In contrast, plasma C2 glucose and plasma C5 glucose ...
Related articles - All 5 versions

Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type …


J Cuthbertson, S Patterson, FPM O'Harte, PM … - Diabetic Medicine, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles - All 3 versions

[PDF] HTA-Bericht zur Effektivität, zur Anwendungssicherheit und zur gesundheitsökonomischen …


TP GmbH - gripsdb.dimdi.de
Im Sommer 2005 wurde im Auftrag von Takeda Pharma GmbH ein HTA-Bericht mit dem
Titel „Bewertung des Mehrnutzens der Therapie mit Glitazonen im Vergleich zur
Therapie mit Metformin oder Sulfonylharnstoffen bei der Behandlung des Typ ...
Related articles


 


Go to Google Home - About Google - About Google Scholar

©2009 Google